AstraZeneca COVID-19 Vaccine Linked To Another Rare Fatal Blood Clotting Disorder VITT from www xvdgos co Watch Video
Preview(s): Play Video: (Note: The default playback of the video is HD VERSION. If your browser is buffering the video slowly, please play the REGULAR MP4 VERSION or Open The Video below for better experience. Thank you!)
Your browser does not support playing the video.Please download the video!
⏲ Duration: 1:46 👁 View: 2.5M times ✓ Published: 16-May-2024
Description: A team of researchers has claimed that British-Swedish pharma giant AstraZeneca's COVID-19 vaccine has been found to raise the risk of VITT or vaccine-induced immune thrombocytopenia and thrombosis, a rare but fatal blood clotting disorder. This came after the company admitted that the vaccine, made in collaboration with Oxford University, can, in very rare cases, cause Thrombotic Thrombocytopenic Syndrome (TTS).<br/>